Form 8-K - Current report:
SEC Accession No. 0001564590-21-047101
Filing Date
2021-09-03
Accepted
2021-09-03 16:10:42
Documents
12
Period of Report
2021-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K (GEOFF RESIGNATION) sana-8k_20210901.htm   iXBRL 8-K 35236
  Complete submission text file 0001564590-21-047101.txt   166583

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sana-20210901.xsd EX-101.SCH 5653
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20210901_lab.xml EX-101.LAB 20078
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20210901_pre.xml EX-101.PRE 11910
5 EXTRACTED XBRL INSTANCE DOCUMENT sana-8k_20210901_htm.xml XML 3682
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 211236610
SIC: 2836 Biological Products, (No Diagnostic Substances)